Agenda

09/09/2026

Understanding ALS, what can we learn from patients?

Rita Levi room at 14:00h

Us convidem al pròxim seminari organitzat pel Programa de Neurociències de l'Hospital del Mar Research Institut que tindrà lloc el pròxim dimecres 09 de setembre a les 14:00 h a la Sala Rita Levi. El títol serà "Understanding ALS, what can we learn from patients?" i anirà a càrrec del Prof. Philip Van Damme, Catedràtic de Neurologia als Hospitals Universitaris de Lovaina (Bèlgica).

___________________________________

We invite you to the upcoming seminar organized by Neuroscience Program of the Hospital del Mar Research Institute, which will take place on Wednesday September 9, at 2:00 pm in the Rita Levi room. The title of the seminar will be:"Understanding ALS, what can we learn from patients?", presented by Prof. Philip Van Damme, professor of neurology at the University Hospitals in Leuven (Belgium).

Poster

Biosketch

Philip Van Damme (MD, PhD) is a professor of neurology at the University Hospitals in Leuven (Belgium), where he is leading the Neuromuscular Reference Center. He studied neurology at KU Leuven medical school. During his neurology training, he did a PhD on disease mechanisms of amyotrophic lateral sclerosis (ALS), and continued to work on this disease after graduating in 2006. In 2008 he was a visiting neuromuscular fellow at the MGH, Boston and visiting researcher at the Day Laboratory for Neuromuscular Research, Harvard Medical School in Boston. Since 2009, he has been appointed as neuromuscular specialist at the neurology department in UZ Leuven and as professor at the department of Neuroscience at KU Leuven. He is leading the ALS program that involves the diagnosis, treatment and multidisciplinary care for patients with ALS. He is actively involved in clinical research, including genetic, biomarker and neuroimaging studies and clinical trials with new treatments for ALS. He currently is the chair of the EAN guideline panel on ALS.

He also is a principal investigator in the laboratory for Neurobiology, Neuroscience Department at the University of Leuven. Within the Leuven Brain Institute he is the founding co-chair of the Leuven Center for ALS research (LEUCALS). His current basic research focuses on genetic modifiers of ALS and on disease pathways in pluripotent stem cell models derived from ALS patients. Philip Van Damme published more than 300 papers in international peer-reviewed journals on ALS and related neuromuscular disorders.

Tots els actes